Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to 'Subcutaneous versus intravenous nivolumab for renal cell carcinoma': [Annals of Oncology volume 36 (2025) 99-107].

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Dexamethasone for prevention of spinal hypotension during caesarean delivery: a randomised controlled trial.

International journal of obstetric anesthesia·2024
Same author

Subcutaneous versus intravenous nivolumab for renal cell carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Real-world deployment of lateral flow SARS-CoV-2 antigen detection in the emergency department to provide rapid, accurate and safe diagnosis of COVID-19.

Infection prevention in practice·2021
Same author

Psychological and professional impact of COVID-19 lockdown on French dermatologists: Data from a large survey.

Annales de dermatologie et de venereologie·2021
Same author

The fate of major dermatology conferences and meetings of 2020: are e-conferences and digital learning the future?

Clinical and experimental dermatology·2020
Same journal

Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease.

Eye (London, England)·2026
Same journal

Oculomics and the NHS: A UK opportunity to translate eye-derived biomarkers into population health.

Eye (London, England)·2026
Same journal

Long-term follow-up and outcomes of a Diabetic Eye Screening Programme in patients aged 80 with no diabetic eye disease at baseline: should we be routinely screening this cohort?

Eye (London, England)·2026
Same journal

Real world experience with faricimab in switched neovascular AMD and evaluation of reloading versus interval matching regimes.

Eye (London, England)·2026
Same journal

"When the lens drew a continent: a cartographic clue to Alport syndrome".

Eye (London, England)·2026
Same journal

Infographic: efficacy and safety of teprotumumab in patients with thyroid eye disease of long duration and low disease activity.

Eye (London, England)·2026
See all related articles

Related Experiment Video

Updated: Jun 18, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

Virtual assessment and glaucoma shared care

D Rathod, S Pickering, M W Austin

    Eye (London, England)
    |November 14, 2009
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    A Gaze-Contingent Display Framework for Perceptual Learning Research with Simulated Central Vision Loss
    07:12

    A Gaze-Contingent Display Framework for Perceptual Learning Research with Simulated Central Vision Loss

    Published on: April 11, 2025

    Related Experiment Videos

    Last Updated: Jun 18, 2026

    Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
    07:11

    Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

    Published on: May 25, 2020

    A Gaze-Contingent Display Framework for Perceptual Learning Research with Simulated Central Vision Loss
    07:12

    A Gaze-Contingent Display Framework for Perceptual Learning Research with Simulated Central Vision Loss

    Published on: April 11, 2025